Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome [Phase 1, Phase 2]
Clinical trial updating sorafenib combined with low-dose cytarabine in older patients with acute myeloid leukemia or high-risk myelodysplast…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Venetoclax and Lintuzumab-Ac225 in AML Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating venetoclax in combination with lintuzumab-acy225 for relapsed or adult acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: 2018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II [Phase 1, Phase 2]
This Phase I/II clinical trial evaluated Interleukin-7 for T-cell recovery after haploidentical and cord blood stem cell transplantation and…
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating ibrutinib to prevent acute leukemia after reduced-intensity conditioning and stem cell transplant.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy [Phase 2]
Phase 2 trial updates efficacy and safety of BST-236 in newly diagnosed acute myeloid leukemia patients unfit for standard induction therapy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children [Phase 2, Phase 3]
Clinical trial update for treatment of newly diagnosed acute monocytic leukemia in children, currently in Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients [Phase 1, Phase 2]
Phase 1/2 trial results for lintuzumab-Ac225 in older adults with acute myeloid leukemia have been completed.
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients [Phase 2]
Phase 2 trial evaluating selinexor with chidamide for relapsed/refractory acute myeloid leukemia is in progress, status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia [Phase 3]
Phase 3 trial comparing Iomab-B to conventional care in older patients with active, relapsed or refractory acute myeloid leukemia is ongoing…
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: Safety and Efficacy of Venetoclax in Combination With Azacitidine and HA Regimen in the Treatment of AML in the Elderly [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating venetoclax with azacitidine and HA regimen for elderly patients with acute myeloid leukemia; current s…
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001) [Phase 1, Phase 2]
Clinical trial update for BOMedemstat in advanced myeloid malignancies (AML and MDS) across Phase 1/2, with and without ATRA; study status c…
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning [Phase 2]
Phase 2 trial update on allogeneic transplantation using timed sequential busulfan and fludarabine conditioning for various hematologic mali…
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome [Phase 1, Phase 2]
Phase 1/2 clinical trial assessing a combination regimen including filgrastim, cladribine, cytarabine, mitoxantrone, and sorafenib in newly …
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Haplo HCT vs Haplo-cord HCT for Patients With AML [Phase 3]
Phase 3 trial comparing haploidentical hematopoietic stem cell transplantation (haplo HCT) versus haplo-cord HCT in patients with acute myel…
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Risk-adapted Therapy for Primary Acute Myeloid Leukemia [Phase 2]
A Phase 2 clinical trial update evaluating risk-adapted therapy for primary acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Phase III rhu_GM-CSF + 3 Induction Regimens in Adults With Acute Non-Lymphocytic Leukemia [Phase 3]
Phase III trial evaluating rhu_GM-CSF combined with three induction regimens in adults over 55 with acute non-lymphocytic leukemia has compl…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia [Phase 2]
Phase 2 trial comparing three regimens in relapsed or refractory acute myeloid leukemia (AML).
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML) [Phase 3]
A global Phase 3 trial evaluating midostaurin plus chemotherapy in newly diagnosed FLT3-mutation negative AML completed with posted results …
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Phase 1 trial of the oxidative phosphorylation inhibitor IACS-010759 in relapsed or refractory acute myeloid leukemia has been terminated wi…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Milademetan Tosylate and Low-Dose Cytarabine With or Without Venetoclax in Treating Participants With Recurrent or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]
Phase 1/2 trial evaluating milademetan tosylate with low-dose cytarabine, with or without venetoclax, in recurrent or refractory acute myelo…
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Efficacy of 5-Aza for Post-Remission Therapy of Acute Myeloid Leukemia (AML) in Elderly Patients [Phase 3]
A Phase 3 trial update on the efficacy of 5-Aza as post-remission therapy for elderly patients with acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: A Study on the Efficacy and Safety of Venetoclax Combined With HAA Regimen in Newly Diagnosed Young AML. [Phase 1, Phase 2]
Early-stage study assessing the efficacy and safety of venetoclax in combination with the HAA regimen for newly diagnosed young patients wit…
-
CLINICAL_TRIALS trial_result · 2023-05-30Clinical Trial Update: Venetoclax+HMA+Aclarubicin Versus Venetoclax+HMA in Treatment-Naive Elderly Patients With AML [Phase 3]
A Phase 3 trial comparing venetoclax plus hypomethylating agent plus aclarubicin versus venetoclax plus HMA in treatment-naive elderly patie…
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS [Phase 2]
Phase 2 trial evaluating nivolumab with oral cyclophosphamide for relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic s…
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: A Study of XY0206 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory AML With FLT3-ITD-Mutation (ALIVE) [Phase 3]
Phase 3 trial comparing XY0206 to salvage chemotherapy in relapsed or refractory AML with FLT3-ITD mutation (ALIVE).